People aren't very happy with Mylan's EpiPen pricing strategy right now. But we think the implementation is to blame, not the prices themselves. Here's why.
Mylan's Prices Weren’t the Problem. Its Implementation Strategy Was.
Posted by TheKiniGroup under FinanceFrom https://thekinigroup.com 2997 days ago
Who Voted for this Story
Subscribe
Comments